0001694665-23-000176.txt : 20231108 0001694665-23-000176.hdr.sgml : 20231108 20231108203156 ACCESSION NUMBER: 0001694665-23-000176 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231107 FILED AS OF DATE: 20231108 DATE AS OF CHANGE: 20231108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILL SIMBA CENTRAL INDEX KEY: 0001180763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 231389718 MAIL ADDRESS: STREET 1: 515 GALVESTON DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE, 600/700, SUITE 7-201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, 600/700, SUITE 7-201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1699493502.xml FORM 4 X0508 4 2023-11-07 0 0001694665 Evelo Biosciences, Inc. EVLO 0001180763 GILL SIMBA C/O EVELO BIOSCIENCES, INC. ONE KENDALL SQUARE, 600/700, SUITE 7-201 CAMBRIDGE MA 02139 1 1 0 0 President & CEO 1 Common Stock 2023-11-07 4 M 0 1172 A 17930 D Common Stock 2023-11-08 4 S 0 172 0.33 D 17758 D Restricted Stock Units 2023-11-07 4 M 0 1172 0 D Common Stock 1172 15236 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $0.32 to $0.34, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the issuer on each such vesting date. The RSUs have no expiration date. /s/ Marella Thorell, Attorney-in-Fact for Balkrishan (Simba) Gill, Ph.D. 2023-11-08